Actively Recruiting
Comparing Nasal Influenza Vaccine Given at Daycare or Healthcare for Children Aged 2 to 6 Years
Led by Turku University Hospital · Updated on 2026-01-22
6000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to determine if offering nasal influenza vaccines to children at daycare centers increases vaccination rates compared to offering vaccines only at healthcare facilities. The study focuses on children attending early childhood education in the city of Turku, assessing how the location of vaccination impacts coverage. Sponsored by Turku University Hospital, the trial evaluates vaccination practices in a real-world setting. Participants will be randomly assigned to one of two groups. The intervention group will have the opportunity to receive a live attenuated nasal influenza vaccine directly at their daycare, while the comparison group will only be able to get vaccinated at healthcare facilities. The study spans from enrollment through the seasonal influenza vaccination period, which lasts approximately 3 to 10 weeks. During the study, researchers will track the proportion of children who receive the influenza vaccine from enrollment until the end of the vaccination season. The primary measurement is influenza vaccination coverage. There is no masking or blinding in this trial, and participation involves receiving or having the opportunity to receive the vaccine at the assigned location. The total participation period aligns with the seasonal influenza vaccination timeline.
CONDITIONS
Brief Title
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
Research Team
V
Ville Peltola, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here